If the drug is effective in Europe, which it is, then the company may proceed asking the FDA for an EUA emergency use authorization, under the Covid pandemic circumstance, and can start selling the drug while going through trials for the final approval. There is an urgent need for this drug because many HIV/AIDS infected patients are at an even higher risk if infected with COVID. The company can use the money from the sale and pay for the trials.
The company may also be getting federal funding as well while all these activities are taking place. Not to mention, they have an effective COVID drug that can be applied for a FDA emergency use authorization after which if granted can start selling that as well
So many catalysts will propel this stock forward